Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results

Table 1

Baseline demographic characteristics and disease history of patients with the relapsing-remitting and secondary progressive form of MS.

	RRMS	SPMS
Number of patients	13	7
Male/female	9/4	3/4
Age	37,4 (range: 27–58)	40,6 (range: 34–51)
Duration of disease (years)	9,5	15,6
Neurologic status, median (range) EDSS score	4,6 (range: 3–6,5)	5,6 (range: 3,5–9)
Relapses 12 months before treatment	1-2	1-2
MRI activity: single-dose gadolinium positive or new or enlarging T2 lesions Gd+ after 12 months of treatment	4	0